SARS CoV 2 News and Research

RSS

Do people experience more anxiety, depression and distress after COVID?

A recent study posted to the medRxiv* preprint server analyzed mental health outcomes after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

18 May 2022

RGS2 protein expression may explain reduced sense of smell in COVID

Researchers tested the hypothesis that anosmia in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected individuals elevates the expression of the odorant receptor, a regulator of G protein signaling 2 (RGS2) in humans.

18 May 2022

Evaluating efficacy of SARS-CoV-2 antivirals in a mouse model

In a recent study posted to the bioRxiv* pre-print server, researchers from Belgium evaluated the efficacy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antiviral drugs in a severe combined immunodeficient (SCID) mouse model.

18 May 2022

SARS-CoV-2 infection could increase the risk of brain degeneration seen in Parkinson's disease

Brain fog, headaches, insomnia are some of the neurological symptoms doctors have observed in COVID-19 patients.

18 May 2022

Recombinant protein vaccine stands up to SARS-CoV-2 variants

A study by researchers in Texas describes a mouse model in which a subunit vaccine with alum-CpG adjuvant was tested for its ability to induce a broadly neutralizing antibody response against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 May 2022

Researchers test how three mutations work together to produce new SARS-CoV-2 variants

Like storm waves battering a ship, new versions of the SARS-CoV-2 virus have buffeted the world one after another. Recently, scientists keeping tabs on these variants noticed a trend: Many carry the same set of three mutations.

18 May 2022

The impact of NSAIDs on COVID-19 severity

Researchers examine potential correlations between NSAID use and COVID-19 severity.

18 May 2022

Should children be vaccinated against COVID-19?

A new study conducted examines issues surrounding children between the ages of five and 11 who are eligible for vaccination against SARS-CoV-2.

18 May 2022

Study explores COVID-19's lingering impacts on survivors and local communities

A Japanese research team looking at COVID-19's lingering impacts on survivors and local communities found that having a mild case of COVID-19, smoking status, comorbidities, or your sex aren't significant predictors to tell if you are less likely to develop long-term symptoms but age is.

18 May 2022

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

18 May 2022

Scientists report complex mutation pattern of Omicron BA.2

Recently, scientists have studied the mutation profile of SARS-CoV-2 Omicron BA.2 and analyzed its outcome based on the interaction with receptor and/or monoclonal antibodies.

18 May 2022

Only some coronaviruses found to have pandemic-causing potential

In a new study, scientists focused on resolving the mystery of why some coronaviruses have the potential of causing a pandemic while others do not.

18 May 2022

STOP-COVID19 trial: Brensocatib did not improve clinical status of patients with severe SARS-CoV-2 infection

Brensocatib did not improve the clinical status of patients hospitalized with severe SARS-CoV-2 infection in the double-blind randomized, placebo-controlled STOP-COVID19 multicenter clinical trial, according to research published at the ATS 2022 international conference.

18 May 2022

SARS CoV 2 News and Research

Do people experience more anxiety, depression and distress after COVID?

RGS2 protein expression may explain reduced sense of smell in COVID

Evaluating efficacy of SARS-CoV-2 antivirals in a mouse model

SARS-CoV-2 infection could increase the risk of brain degeneration seen in Parkinson's disease

Recombinant protein vaccine stands up to SARS-CoV-2 variants

Researchers test how three mutations work together to produce new SARS-CoV-2 variants

The impact of NSAIDs on COVID-19 severity

Should children be vaccinated against COVID-19?

Study explores COVID-19's lingering impacts on survivors and local communities

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

Scientists report complex mutation pattern of Omicron BA.2

Only some coronaviruses found to have pandemic-causing potential

STOP-COVID19 trial: Brensocatib did not improve clinical status of patients with severe SARS-CoV-2 infection

Treatment with imatinib results in lower mortality rates for patients with severe COVID-19

Study explores lipid nanoparticles against SARS-CoV-2

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

Study explores neurologic complications in pediatric COVID-19 cases

Gestational diabetes mellitus in overweight and obese pregnant women may increase COVID-19 severity

Combined COVID-19 vaccination regimen found to induce more potent anti-SARS-CoV-2 antibodies

Case report: human breast milk from vaccinated woman clears persistent SARS-CoV-2 infection

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News